Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular

Andrew M N Walker1, Michael Drozd1, Marlous Hall1

  • 11 Leeds Institute of Cardiovascular and Metabolic Medicine The University of Leeds United Kingdom.

Insights

Sepsis caused over 23% of deaths in chronic heart failure (CHF) patients, often from respiratory infections. Risk factors include older age, COPD, and higher platelet counts, suggesting targeted prevention strategies for heart failure sepsis are possible.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Noncardiovascular mortality is a growing concern in chronic heart failure (CHF).
  • The specific causes and risk factors for sepsis-related deaths in CHF patients are not well understood.

Purpose of the Study:

  • To determine the prevalence of sepsis as a cause of death in patients with CHF.
  • To identify the risk marker profile associated with sepsis death in this population.

Main Methods:

  • A prospective cohort study involving 1802 CHF patients with left ventricular ejection fraction ≤45% was conducted.
  • Mode of death was assessed over a mean follow-up of 4 years (10.3-year maximum).
  • Competing risk regression was used to analyze hazard ratios for different causes of death.

Main Results:

  • Sepsis accounted for 173 (23.5%) of 737 deaths, with respiratory tract infections being the most common cause (69.9%).
  • Sepsis deaths were associated with older age, higher platelet counts, and chronic obstructive pulmonary disease (COPD).
  • Independent risk factors for sepsis death included older age, COPD, male sex, lower serum vitamin D, and higher platelet count.

Conclusions:

  • Sepsis is a significant cause of mortality in patients with chronic heart failure.
  • The distinct risk marker profile for sepsis death suggests potential for targeted preventative interventions in heart failure management.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
929
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
886
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
340
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
971
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319